Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120250503 | 12025050 | 3 | F | 2015 | 20160816 | 20160206 | 20160826 | EXP | US-ABBVIE-15K-163-1481539-00 | ABBVIE | 52.51 | YR | M | Y | 102.15000 | KG | 20160826 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120250503 | 12025050 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | LOADING DOSE | 1034113 | 125057 | 80 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 120250503 | 12025050 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1034113 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 120250503 | 12025050 | 3 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 120250503 | 12025050 | 4 | C | OTEZLA | APREMILAST | 1 | 0 | ||||||||||||
| 120250503 | 12025050 | 5 | C | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | FOR 10 DAYS | 0 | 1 | DF | CAPSULE | Q8H | ||||||
| 120250503 | 12025050 | 6 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | 0 | OINTMENT | |||||||||||
| 120250503 | 12025050 | 7 | C | CLOBETASOL | CLOBETASOL | 1 | APPLY TO AFFECTED AREA FOR TWO TO FOUR WEEKS | 0 | OINTMENT | BID | |||||||||
| 120250503 | 12025050 | 8 | C | CLOBETASOL | CLOBETASOL | 1 | SPRAY, UPTO 3 WEEKS THEN OFF FOR 10 DAYS | 0 | |||||||||||
| 120250503 | 12025050 | 9 | C | AMOXCLAV | 2 | Oral | 875-125 MILLIGRAM, FOR 10 DAYS | 0 | 1 | DF | TABLET | BID | |||||||
| 120250503 | 12025050 | 10 | C | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 120250503 | 12025050 | 11 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | Oral | IF NEEDED | 0 | 1 | DF | TABLET | Q6H | ||||||
| 120250503 | 12025050 | 12 | C | IVERMECTIN. | IVERMECTIN | 1 | Oral | TAKE 6 TABLETS BY MOUTH ONCE, REPEAT IN 2 WEEKS | 0 | TABLET | |||||||||
| 120250503 | 12025050 | 13 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | APPLY TO AFFECTED AREA TWICE A DAY TO THREE TIMES A DAY | 0 | CREAM | ||||||||||
| 120250503 | 12025050 | 14 | C | PREDNISONE. | PREDNISONE | 1 | Oral | WITH FOOD | 0 | TABLET | BID | ||||||||
| 120250503 | 12025050 | 15 | C | PERMETHRIN. | PERMETHRIN | 1 | MASSAGE INTO SKIN FROM HEAD TO SOLES OF FEET, WASH OFF AFTER 8 TO 14 HRS | 0 | CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120250503 | 12025050 | 1 | Psoriasis |
| 120250503 | 12025050 | 3 | Product used for unknown indication |
| 120250503 | 12025050 | 4 | Psoriasis |
| 120250503 | 12025050 | 5 | Product used for unknown indication |
| 120250503 | 12025050 | 6 | Product used for unknown indication |
| 120250503 | 12025050 | 7 | Product used for unknown indication |
| 120250503 | 12025050 | 9 | Product used for unknown indication |
| 120250503 | 12025050 | 10 | Product used for unknown indication |
| 120250503 | 12025050 | 11 | Pain |
| 120250503 | 12025050 | 12 | Product used for unknown indication |
| 120250503 | 12025050 | 13 | Product used for unknown indication |
| 120250503 | 12025050 | 14 | Product used for unknown indication |
| 120250503 | 12025050 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120250503 | 12025050 | HO |
| 120250503 | 12025050 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120250503 | 12025050 | Blood pressure increased | |
| 120250503 | 12025050 | Cellulitis | |
| 120250503 | 12025050 | Depression | |
| 120250503 | 12025050 | Emotional distress | |
| 120250503 | 12025050 | Gait disturbance | |
| 120250503 | 12025050 | Joint range of motion decreased | |
| 120250503 | 12025050 | Nail disorder | |
| 120250503 | 12025050 | Onychoclasis | |
| 120250503 | 12025050 | Psoriatic arthropathy | |
| 120250503 | 12025050 | Pustular psoriasis | |
| 120250503 | 12025050 | Pyoderma gangrenosum | |
| 120250503 | 12025050 | Rheumatoid factor increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120250503 | 12025050 | 1 | 20150218 | 20150218 | 0 | |
| 120250503 | 12025050 | 2 | 20150225 | 201507 | 0 | |
| 120250503 | 12025050 | 3 | 20150729 | 20150729 | 0 | |
| 120250503 | 12025050 | 5 | 20160106 | 0 | ||
| 120250503 | 12025050 | 6 | 20151222 | 0 | ||
| 120250503 | 12025050 | 7 | 20151123 | 0 | ||
| 120250503 | 12025050 | 8 | 20151006 | 0 | ||
| 120250503 | 12025050 | 9 | 20151005 | 0 | ||
| 120250503 | 12025050 | 10 | 20150916 | 0 | ||
| 120250503 | 12025050 | 11 | 20150916 | 0 | ||
| 120250503 | 12025050 | 12 | 20150707 | 0 | ||
| 120250503 | 12025050 | 13 | 20150707 | 0 | ||
| 120250503 | 12025050 | 14 | 20150624 | 0 | ||
| 120250503 | 12025050 | 15 | 20150622 | 0 |